Kramar Andrew, Paoletti Xavier
Unité de Biostatistiques, Centre régional de lutte contre le cancer Val d'Aurelle-Paul Lamarque, Montpellier.
Bull Cancer. 2007 Nov;94(11):965-74.
The methodological principles for the planning of interim analyses in a phase III clinical trial are presented in this article. The case for superiority, non-inferiority and futility, and the roles of Data Monitoring Committees are summarized. Several examples are presented to illustrate the methodology and to help investigators by better understanding and planning interim analyses in a phase III clinical trial.
本文介绍了III期临床试验中期分析规划的方法学原则。总结了优效性、非劣效性和无效性的情况以及数据监测委员会的作用。给出了几个例子来说明该方法,并帮助研究者更好地理解和规划III期临床试验中的中期分析。